Pinar Zorlutuna and a team of University researchers have created a new type of diode, one that is made entirely of cardiac muscle cells and fibroblasts. Their recently published paper titled “Muscle-Cell-Based ‘Living Diodes’” discusses how using muscle cells as the diode components is ideal for cell-based information processing. An...

It’s been one year since the World Health Organization (WHO) declared Zika a public health emergency. The virus, transmitted through the Aedes aegypti mosquito, has since been declared to be a long-term problem rather than an emergency, but Zika continues to concern health professionals. At the Eck Institute for Global...

Biological sciences graduate student Joshua Mason has been selected to attend the 2017 National Graduate Student Symposium (NGSS) at St. Jude Children’s Research Hospital in Memphis, Tennessee. Selection in the NGSS is extraordinarily competitive as application is by invitation only. Over 1,500 students were invited to apply for the 2017...

A collaborative modeling study among three research groups, including Edwin Michael’s laboratory in the Department of Biological Sciences, reveals that a triple-drug regimen could accelerate the elimination of lymphatic filariasis, a mosquito-borne parasitic disease also known as elephantiasis. The study, which shows that the regimen requires far fewer applications than...

Assistant Professor Robert Rosenbaum, in the Department of Applied and Computational Mathematics and Statistics (ACMS), coauthored a paper that was recently published in the journal Nature Neuroscience titled “The spatial structure of correlated neuronal variability.” In the paper, a culmination of research in collaboration with the University of Pittsburgh, the...

Immunologists are changing how we look at cancer by studying how our immune system plays a role in treating cancer. Brian Baker, Ph.D., and his lab in the Harper Cancer Research Institute and Department of Chemistry and Biochemistry were recently awarded a $4 million, 5-year grant from the National Institutes...

Alex Perkins, PhD, Eck Family Assistant Professor in the Department of Biological Sciences, and a member of the Eck Institute for Global Health, is among the “Best of 2016” editor’s top 10 picks for the publication Nature Microbiology, a nature research journal. According to the publication, each year the most...

For the fourth year in a row, the University of Notre Dame’s John J. Reilly Center for Science, Technology and Values has released a list of emerging ethical dilemmas and policy issues in science and technology. The 2017 list includes freezing brains and swarms of drones and highlights issues in...

Research in the laboratory of Rebecca Wingert, the Gallagher Family Associate Professor of Adult Stem Cell Research in the Department of Biological Sciences at the University of Notre Dame, has confirmed the key role of a certain small molecule in the development of kidney structures in zebrafish, a widely used...

Notre Dame Researcher Developing Medication Delivery System to Combat Diabetes Diabetes is a metabolic disease in which the body has an inability to produce enough insulin. In the United States alone, it is estimated that the illness affects nearly 30 million diagnosed and undiagnosed people, and treatment often includes patients...

Matthew Webber tested a novel route for non-covalent protein modification and results reveal a new way to improve the stability of common protein drugs and extend shelf-life.

Alex Perkins, PhD, Eck Family Assistant Professor in the Department of Biological Sciences, and a member of the Eck Institute for Global Health, along with Guido Espana who holds a postdoctoral position in the Perkins laboratory, were recently published in the journal PLoS Medicine. The results of their study are...

A new Notre Dame research program looks for solutions to the problem of medical nonadherence As part of the launch of a new research program in Health-Related Behavioral Sciences, the University of Notre Dame’s Advanced Diagnostics & Therapeutics initiative has made its first award to support an investigation of why...

In July, 2014, Mike Patterson received some news that changed his life forever. He was diagnosed with stage four colon and liver cancer. “They didn’t give me a lot of hope,” recalled Patterson. Like many patients after receiving such a diagnosis, Mike asked for a second opinion. However, he was...

Notre Dame Researcher Developing Medication Delivery System to Combat Diabetes Diabetes is a metabolic disease in which the body has an inability to produce enough insulin. In the United States alone, it is estimated that the illness affects nearly 30 million diagnosed and undiagnosed people, and treatment often includes patients...

One in 77 women will develop ovarian cancer in her lifetime.  Because ovarian cancer has no defined symptoms, most women will be diagnosed at a late stage of the disease where metastatic lesions are found dispersed throughout the abdomen.  Ovarian cancer is currently the fifth most common cause of cancer-related...

Pancreatic cancer, the third leading cause of cancer-related deaths, is projected to be the second by the year 2030, according to a study in the journal of Cancer Research. The five-year survival rate is only 8 percent, making it the only major cancer with a survival rate in the single...

The American Cancer Society has reported that lung cancer, which kills more Americans than any other type of cancer, is expected result in an estimated 158,080 deaths in 2016. Although drugs are currently available to fight lung cancer, drug discovery challenges persist because treatment options are limited. Not only is...

Indiana CTSI grants encourage use of core facilities throughout the State The Indiana Clinical and Translational Sciences Institute (CTSI) announced that University of Notre Dame researchers have been awarded grants through the CTSI Pilot Funding program. The program is intended to promote the use of technologies and expertise available through...

In the United States alone, there are nearly 240,000 breast cancer diagnoses each year, and one in eight women will develop breast cancer at some point in her lifetime. To date, mammograms are the best diagnostic technology for breast cancer. A mammogram’s ability to detect tumors at early stages has...